Filters
clear all
Filters
Topics
Markets
Type
Brand
Workers' Comp Case Study

Home Team Advantage

August 13, 2019
2 MIN READ

Field Case Management Meet Theresa Martin, RN, BSN, CCM Theresa Martin, RN, BSN, CCM, is a second-career nurse case manager who worked as a flight a

genex Article

Claims Magazine: 8 Strategies for Combating Opioid Addiction

August 4, 2019
1 MIN READ

When employees injure themselves at work, a potentially lethal risk may ensue — they may be prescribed and become addicted to an opioid painkiller. As we know, the United States is currently experiencing an opioid epidemic — with

Workers' Comp Case Study

Man Down, but Not for Long

August 2, 2019
2 MIN READ

Meet Carrie McCullin, RN, CCM. Carrie McCullin has more than a decade of case management experience at Genex Services, and has been an RN for more than 25 years. Known for her excellent critical thinking skills and ability to handle crises no matter the day or hour, these characteristics came into play when McCullin fielded a call one Saturday morning.

Workers' Comp Case Study

Rising from the Fall

August 2, 2019
2 MIN READ

Catastrophic Case Management Meet Carolyn Lau, MBA, RN, CCM Carolyn Lau is a seasoned catastrophic case manager who has successfully managed numerou

genex Article

StateWatch: Bill Review July 2019

July 22, 2019
4 MIN READ

Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.

Mitchell Article

Opioids in 2019: Insights into New Regulations and Studies of the Epidemic

July 3, 2019

Momentum in battling the opioid crisis continues. As more states enact opioid prescribing limits, the federal government proposes new legislation, while new studies look at the impact of opioid laws and medical marijuana on lessening opioid abuse.

Mitchell Article

How Naloxone Can Help Fight the Opioid Crisis

July 2, 2019

As the U.S. looks for ways to stem the opioid crisis, one major strategy that has emerged is the use of naloxone to counteract opioid overdoses. The FDA’s recent approval of the generic form of Narcan®, which is the first generic formulation for naloxone nasal spray, provides another avenue to reverse the impact of the opioid crisis.